Ad is loading...
MUHLX
Price
$73.88
Change
+$0.58 (+0.79%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
+$0.84 (+1.22%)
Updated
Nov 21 closing price
Ad is loading...

MUHLX vs VVIAX

Header iconMUHLX vs VVIAX Comparison
Open Charts MUHLX vs VVIAXBanner chart's image
Muhlenkamp
Price$73.88
Change+$0.58 (+0.79%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change+$0.84 (+1.22%)
VolumeN/A
CapitalizationN/A
MUHLX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MUHLX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MUHLX is a StrongBuy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. MUHLX (253M). VVIAX pays higher dividends than MUHLX: VVIAX (2.36) vs MUHLX (0.83). MUHLX was incepted earlier than VVIAX: MUHLX (36 years) vs VVIAX (24 years). MUHLX is a more actively managed with annual turnover of: 14.72 vs. VVIAX (10.00). MUHLX has a lower initial minimum investment than VVIAX: MUHLX (1500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. MUHLX (24.50). MUHLX return over 5 years is better than : 61.13 vs. VVIAX (53.09).
MUHLXVVIAXMUHLX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence36 years24 years-
Gain YTD18.72119.67295%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets253M184B0%
Annual Yield % from dividends0.832.3635%
Returns for 1 year24.5026.0994%
Returns for 3 years24.1024.7797%
Returns for 5 years61.1353.09115%
Returns for 10 years8.07112.267%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics